Capricor Therapeutics Inc (CAPR.OQ)
CAPR.OQ on NASDAQ Stock Exchange Capital Market
0.43USD
15 Feb 2019
0.43USD
15 Feb 2019
Change (% chg)
$0.02 (+3.73%)
$0.02 (+3.73%)
Prev Close
$0.41
$0.41
Open
$0.41
$0.41
Day's High
$0.44
$0.44
Day's Low
$0.41
$0.41
Volume
55,174
55,174
Avg. Vol
41,741
41,741
52-wk High
$1.99
$1.99
52-wk Low
$0.31
$0.31
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.22 | -0.135 |
| Jun '18 | 0.40 | -0.142 | |
| Mar '18 | 0.40 | -0.136 | |
| FY 2017 | Dec '17 | 0.48 | 0.306 |
| Sep '17 | 0.31 | -0.117 | |
| Jun '17 | 1.00 | -0.157 | |
| Mar '17 | 0.88 | -0.171 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-19 | 2 | 0.65 | 1.30 | 0.00 | 2.90 |
| Earnings (per share) | |||||
| Year Ending Dec-19 | 2 | -0.50 | -0.50 | -0.50 | -0.61 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.44 | 33.70 | |
| P/E High - Last 5 Yrs. | -- | 147.79 | 49.87 | |
| P/E Low - Last 5 Yrs. | -- | 47.97 | 24.25 | |
| Beta | -2.65 | 1.08 | 0.90 | |
| Price to Sales (TTM) | 19.03 | 49.51 | 6.29 | |
| Price to Book (MRQ) | -- | 10.14 | 5.26 | |
| Price to Tangible Book (MRQ) | -- | 13.78 | 6.77 | |
| Price to Cash Flow (TTM) | -- | 56.20 | 24.98 | |
| % Owned Institutions | 3.23 | 3.74 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.85 | |
| Payout Ratio(TTM) | -- | 7.02 | 41.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -11.80 | 205.92 | 12.75 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -26.18 | 48.79 | 5.84 | |
| Sales - 5 Yr. Growth Rate | 24.17 | 22.76 | 11.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 39.94 | 75.85 | 47.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 8.12 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 11.98 | 10.85 | |
| Capital Spending - 5 Yr. Growth Rate | 149.85 | 9.07 | 15.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.24 | 2.25 |
| Current Ratio (MRQ) | 0.82 | 3.50 | 3.08 |
| LT Debt to Equity (MRQ) | -- | 18.65 | 11.38 |
| Total Debt to Equity (MRQ) | -- | 31.33 | 16.12 |
| Interest Coverage (TTM) | -58.74 | -43.11 | 29.47 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.24 | 53.81 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.48 | 52.18 | |
| EBITD Margin (TTM) | -423.45 | -- | -- | |
| EBITD - 5 Yr. Avg | -265.04 | -110.40 | 12.87 | |
| Operating Margin (TTM) | -470.06 | -184.63 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | -287.51 | -126.89 | 8.31 | |
| Pre-Tax Margin (TTM) | -481.18 | -175.33 | 7.16 | |
| Pre-Tax Margin - 5 Yr. Avg. | -292.39 | -132.68 | 8.61 | |
| Net Profit Margin (TTM) | -481.18 | -182.03 | 3.30 | |
| Net Profit Margin - 5 Yr. Avg. | -292.39 | -137.07 | 4.89 | |
| Effective Tax Rate (TTM) | -- | 22.48 | 22.91 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.51 | 23.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 7,654,601 | 842,398,385 | |
| Net Income/Employee (TTM) | -- | 562,114 | 99,842,801 | |
| Receivable Turnover (TTM) | 13.29 | 6.23 | 5.71 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.47 | |
| Asset Turnover (TTM) | 0.25 | 0.32 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -120.88 | 6.39 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | -96.30 | 5.47 | 12.20 | |
| Return on Investment (TTM) | -645.84 | 8.92 | 14.45 | |
| Return on Investment - 5 Yr. Avg. | -149.85 | 6.78 | 15.87 | |
| Return on Equity (TTM) | -- | 10.08 | 15.96 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.32 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -27.53 | 99.55 | 24.17 |
| EPS (TTM) % | -25.39 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Capricor Therapeutics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 177.67 | 168.10 | 99 | 99 |
| 13 Week | 326.87 | 306.08 | 99 | 95 |
| 26 Week | -0.69 | -8.24 | 99 | 98 |
| 52 Week | -15.13 | -28.07 | 78 | 72 |
| YTD | 7.52 | -5.58 | 99 | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 5.35% |
| # of Holders: | 22 |
| Total Shares Held: | 1,660,959 |
| 3 Mo. Net Change: | -527,643 |
| # New Positions: | 2 |
| # Closed Positions: | 3 |
| # Increased Positions: | 5 |
| # Reduced Positions: | 8 |
| # Net Buyers: | -3 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.